Lippo Karawaci Tbk (LPKR)
Jakarta Exchange · Indonesia · prices in IDR · close of 20 Oct 2026
Key indicators
| Last close | IDR 40.00 |
|---|---|
| 52-week range | 37.00 – 143.00 |
| Return, 1 month / 3 months | −23.1% / −37.5% |
| Return, 1 year / 3 years | −57.0% / −58.3% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 60.1% |
| Worst drawdown (1 year) | -70.3% |
| Average daily value traded | 11,104.11M IDR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lippo Karawaci is an Indonesian property company based in the Jakarta area. It develops residential townships and mixed-use estates, building houses and neighbourhoods for homebuyers, and it also develops and manages commercial properties such as shopping centres and hotels. Through its subsidiaries the company operates hospitals and healthcare services, serving patients in Indonesian cities. Its customers include individual homebuyers, retail tenants, hotel guests and patients, and its activities centre on the Indonesian property and healthcare markets.
On this site Lippo Karawaci Tbk appears as a stock on the Jakarta Exchange (Indonesia), code LPKR, with prices in Indonesian rupiah (IDR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lippo Karawaci Tbk (LPKR) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 40.00 on 20 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 772 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 57.0% and over the last three months it fell 37.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -45.3% | ||
| From 52-week high | -68.8% | ||
| Momentum | 9 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -37.5% | ||
| 6-month return | -51.8% | ||
| 12-month return, skipping the last month | -44.1% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 60.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -70.3% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 11,104.11M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −11.1% |
|---|---|
| 1 month | −23.1% |
| 3 months | −37.5% |
| 6 months | −51.8% |
| 1 year | −57.0% |
| 3 years | −58.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 54.86 / 73.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.29 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.